Correlation Between Pfizer and Rbc Emerging

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Rbc Emerging at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Rbc Emerging into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Rbc Emerging Markets, you can compare the effects of market volatilities on Pfizer and Rbc Emerging and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Rbc Emerging. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Rbc Emerging.

Diversification Opportunities for Pfizer and Rbc Emerging

0.77
  Correlation Coefficient

Poor diversification

The 3 months correlation between Pfizer and Rbc is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Rbc Emerging Markets in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rbc Emerging Markets and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Rbc Emerging. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rbc Emerging Markets has no effect on the direction of Pfizer i.e., Pfizer and Rbc Emerging go up and down completely randomly.

Pair Corralation between Pfizer and Rbc Emerging

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Rbc Emerging. In addition to that, Pfizer is 2.01 times more volatile than Rbc Emerging Markets. It trades about -0.22 of its total potential returns per unit of risk. Rbc Emerging Markets is currently generating about -0.1 per unit of volatility. If you would invest  1,302  in Rbc Emerging Markets on August 31, 2024 and sell it today you would lose (25.00) from holding Rbc Emerging Markets or give up 1.92% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  Rbc Emerging Markets

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest sluggish performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
Rbc Emerging Markets 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Rbc Emerging Markets has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Rbc Emerging is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pfizer and Rbc Emerging Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Rbc Emerging

The main advantage of trading using opposite Pfizer and Rbc Emerging positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Rbc Emerging can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rbc Emerging will offset losses from the drop in Rbc Emerging's long position.
The idea behind Pfizer Inc and Rbc Emerging Markets pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities